Activity of mecillinam against ESBL producers in vitro

被引:44
作者
Thomas, K
Weinbren, MJ
Warner, M
Woodford, N
Livermore, D
机构
[1] Univ Hosp Coventry & Warwickshire, Coventry & Warwickshire Hosp, Dept Microbiol, Coventry CV1 4FH, W Midlands, England
[2] Hlth Protect Agcy, Ctr Infect, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
关键词
CTX-M; TEM; antimicrobial resistance;
D O I
10.1093/jac/dki451
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:367 / 368
页数:2
相关论文
共 8 条
[1]   BSAC standardized disc susceptibility testing method (version 4) [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :60-76
[2]  
ANTIPOV AV, 1987, ANTIBIOT MED BIOTEK, V32, P683
[3]   Detection of extended-spectrum β-lactamases in klebsiellae with the oxoid combination disk method [J].
Carter, MW ;
Oakton, KJ ;
Warner, M ;
Livermore, DM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4228-4232
[4]   Pivmecillinam - therapy of choice for lower urinary tract infection [J].
Graninger, W .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 :S73-S78
[5]   CTX-M: changing the face of ESBLs in the UK [J].
Livermore, DM ;
Hawkey, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) :451-454
[6]   ANTIBACTERIAL CHARACTERISTICS OF YTR-830, A SULFONE BETA-LACTAMASE INHIBITOR, COMPARED WITH THOSE OF CLAVULANIC ACID AND SULBACTAM [J].
MOOSDEEN, F ;
WILLIAMS, JD ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) :925-927
[7]   Pivmecillinam in the treatment of urinary tract infections [J].
Nicolle, LE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 :35-39
[8]   Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory [J].
Paterson, DL ;
Ko, WC ;
Von Gottberg, A ;
Casellas, JM ;
Mulazimoglu, L ;
Klugman, KP ;
Bonomo, RA ;
Rice, LB ;
McCormack, JG ;
Yu, VL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) :2206-2212